Home
Home

Regeneron

How The Global Pharma Industry Will Shape Up In The Next 5 Years?

How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha

PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst

PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha

Four Biotech 'Surprise' Stocks for 2014

Four Biotech 'Surprise' Stocks for 2014
TheStreet.com

Ampio Hides Need For New Eye Drug Study in SEC Filing

Ampio Hides Need For New Eye Drug Study in SEC Filing
TheStreet.com

3 New Cholesterol Treatments Worth Watching

3 New Cholesterol Treatments Worth Watching
Motley Fool

Regeneron's Eylea Approved by Japanese Regulator

Regeneron's Eylea Approved by Japanese Regulator
Motley Fool

The Four Horseman of Pharma

The Four Horseman of Pharma
CNBC

Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study

Sanofi Rheumatoid Arthritis Drug Reduces Pain, Damage in Study
Bloomberg

A Shifting Paradigm in Heart Disease Could Affect These Drugmakers

A Shifting Paradigm in Heart Disease Could Affect These Drugmakers
Motley Fool

FDA says new cholesterol drugs may not need outcome studies

FDA says new cholesterol drugs may not need outcome studies
Yahoo/Reuters